What we do Poly Medicure is a global manufacturer of diverse medical devices, specializing in infusion therapy, oncology, anesthesia, and more, serving over 110 countries. |
Founded in 1,995 |
Market share Poly Medicure holds a strong position in the global medtech market with extensive manufacturing across India, China, Egypt, and Italy and a pan-India distributor network. |
Problem solved It provides critical medical disposables improving patient care in hospitals and clinics worldwide, addressing needs in infusion, renal care, surgery, and veterinary solutions. |
Top clients or who we serve The company serves hospitals, clinics, and healthcare providers globally (B2B), with a vast distributor network and exports to over 110 countries. |
Key management - |
Our journey and innovations Since 1995, it expanded globally with advanced manufacturing, earned multiple international certifications, and pioneered products in oncology and cardiology sectors. |
Where we operate Operations span India, China, Egypt, Italy, and exports to Europe, Americas, Asia, Africa, and Australia. |
Top products or what we offer Over 130 medical device SKUs including infusion sets, renal products, oncology disposables, and cardiology devices. |
Top brands Includes infusion therapy sets, renal dialysis catheters, oncology disposables, and cardiovascular products (key revenue drivers with global reach). |
Raw materials needed Specialized medical-grade plastics and polymers. |
Raw materials supplier Global suppliers of medical-grade plastics and components. |
Recurring vs cyclical contribution Revenue is primarily recurring from consistent demand in healthcare consumables. |
Our industry position Among the leading Indian medtech exporters with growing international presence and increasing market share in advanced markets. |
Financial highlights For FY 2024-25, consolidated revenue Rs. 1669.83 Cr, PAT Rs. 338.56 Cr, showing 22% revenue and 31% PAT growth YoY. |
Geographical revenue split Domestic contributes ~31%, international markets ~69%, with strong growth in Europe and rest of world markets. |
Order book - |
Whats driving growth Product innovation, expanding global footprint, regulatory approvals, and increased healthcare spending drive growth. |
Our future plans Expansion of manufacturing capacities in India, entering cardiology and critical care segments, and inorganic growth initiatives. |
Our green promise Committed to sustainability via solar power JV, lean manufacturing, and electronic communications with stakeholders. |
Our people and values Employee focus on engagement, skill development, and wellness programs fostering a positive work culture. |
Key challenges ahead Managing global regulatory risks, foreign exchange volatility, skilled manpower shortage, and competitive pricing pressures. |
Interesting facts Winner of Forbes Asia Best under a Billion (2020) and multiple export excellence and innovation awards. |
Risks and strategy Mitigates risks via diversified markets, robust R&D, stringent quality controls, and proactive regulatory compliance. |
